Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Prilocaine + bupivacaine is a combination anesthetic regimen being evaluated by **Ain Shams University** for the management of **postoperative pain** in patients undergoing ambulatory knee arthroscopy. This protocol, often referred to as "hybrid anesthesia," utilizes intrathecal hyperbaric prilocaine to provide rapid-onset, short-duration spinal anesthesia suitable for day-case surgery, combined with a peripheral nerve block (adductor canal block) using bupivacaine to provide extended postoperative analgesia. Both agents are amino-amide local anesthetics that function by inhibiting voltage-gated sodium channels on the neuronal membrane, thereby preventing the initiation and conduction of nerve impulses. The primary goal of this combination is to minimize the prolonged motor block typically associated with spinal bupivacaine while maintaining effective long-term pain control.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on prilocaine + bupivacaine.